XML 34 R19.htm IDEA: XBRL DOCUMENT v3.21.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
SCHEDULE OF STOCK BASED COMPENSATION

The following table summarizes stock option-based compensation for the three months ended March 31, 2021 and 2020:

 

   For the three months ended March 31, 
   2021   2020 
Research and development  $609,000   $744,000 
General and administrative   474,000    512,000 
Stock option-based compensation expense  included in operating expense   1,083,000    1,256,000 
           
Total stock option-based compensation expense   1,083,000    1,256,000 
Tax benefit   -    - 
Stock option-based compensation expense, net of tax  $1,083,000   $1,256,000 
SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS TO ESTIMATE THE FAIR VALUE OF THE OPTIONS GRANTED

We used the following weighted-average assumptions to estimate the fair value of the options granted for the periods indicated:

 

   For the three months ended March 31, 
   2021   2020 
Expected volatility   99%    111% 
Expected term   6.08 years    6.25 years 
Risk-free interest rate   1.00%    0.43% 
Expected dividend yield   0%    0% 

SCHEDULE OF OPTIONS ACTIVITY

The following table summarizes the options granted for the periods indicated:

 

   For the three months ended March 31, 
   2021   2020 
Options granted   2,149,500    1,175,927 
Weighted-average:          
Exercise price  $2.29   $1.45 
Grant date fair value  $1.80   $1.21 

Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
SCHEDULE OF STOCK BASED COMPENSATION

Restricted Common Stock: The following table summarizes restricted common stock compensation expense for the three months ended March 31, 2021 and 2020:

 

   For the three months ended March 31, 
   2021   2020 
Research and development  $546,000   $325,000 
General and administrative   321,000    139,000 
Restricted stock-based compensation expense included in operating expense   867,000    464,000 
           
Total restricted stock-based compensation expense   867,000    464,000 
Tax benefit   -    - 
Restricted stock-based compensation expense, net of tax  $867,000   $464,000